Our findings found that PRPS2 can regulate nucleotide de novo synthesis to change breast cancer cell stem–like properties in the metastasis, strongly suggesting PRPS2 can be a new specific therapeutic target for breast cancer treatment. This evidence concerns the gene PRPS2 and breast carcinoma.